Inventor
Alistair Lochead
Inventor
Charenton-le-Pont, FR
Overview
Patents· 75 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes21%
Y02ATechnologies for adaptation to climate change5%
A01NPreservation of bodies of humans or animals or plants or parts thereof3%
Y02PClimate change mitigation technologies in the production or processing of goods1%
PatentTitleYear
9,073,914'Substituted alkyl pyrimidin-4-one derivatives'20159,073,915'Substituted pyrimidone derivatives'20158,889,702'Derivatives of azaspiranyl-alkylcarbamates of 5-member heterocyclic compounds, preparation thereof and therapeutic use thereof'20148,865,738'5-membered heterocyclic compound cyclopenta[C]pyrrolylalkylcarbamate derivatives, preparation thereof, and therapeutic use thereof'20148,759,343'Azabicycloalkane derivatives, preparation thereof and use thereof in therapy'20148,614,219'Substituted pyrimidin-4-one derivatives'20138,598,187'Arylamide pyrimidone compounds'20138,598,175'Heteroarylamide pyrimidone derivatives'20138,592,580'Substituted triazinone derivatives'20138,592,436'Arylamide pyrimidone derivatives'20138,592,437'Heteroarylamide pyrimidone compounds'20138,557,819'Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics'20138,541,440'Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics'20138,524,706'1,4-diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof'20138,507,475'Substituted heteroarylamide diazepinopyrimidone derivatives'20138,507,470'Substituted arylamide oxazepinopyrimidone derivatives'20138,507,476'Substituted arylamide diazepinopyrimidone derivatives'20138,501,728'Substituted heteroarylamide oxazepinopyrimidone derivatives'20138,394,787'7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof and therapeutic use thereof'20138,273,758'Substituted tricyclic derivatives'20128,211,903'Substituted pyrimido isoquinoline derivatives'20128,202,874'Substituted N-oxide pyrazine derivatives'20128,198,287'Substituted heteroaryl pyridopyrimidone derivatives'20128,173,669'Azabicycloalkane derivatives, preparation thereof and use thereof in therapy'20128,148,364'Substituted bicyclic pyrimidone derivatives'20128,093,256'Use of 8-substituted-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives'20128,076,340'Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics'20117,863,290'Derivatives of 5-pyridinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics'20117,781,440'Use of substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives'20107,608,624'1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7-pyridinyl-imidazo[1,2-a]pyrimidin-5(1h)-one derivatives'20097,589,201'Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics'20097,585,974'Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, their preparation and their therapeutic application'20097,566,720'2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives'20097,547,705'Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives'20097,507,743'Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a] pyrimidin-6-one derivatives'20097,476,674'Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics'20097,465,737'Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl -6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives'20087,462,621'Use of substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a] pyrimidin-5(1H)one derivatives as therapeutic agents'20087,456,171'1,4-Diazabicyclo[3.2.2]nonanecarboxamide derivatives, preparation and therapeutic use thereof'20087,452,897'Use of substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives for the treatment of neurodegenerative diseases'20087,429,663'7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors'20087,393,853'Use of substituted 8-Perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives as therapeutic agents'20087,388,005'Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo [1,2-a]pyrimidin-5(1H)one derivatives for neurodegenerative disorders'20087,294,631'Substituted 8′-pyri(MI)dinyl-dihydrospiro-[cycloalkylamine]-pyrimido[1,2-a]pyrimidin-6-one derivatives'20077,294,632'Substituted 8′-pyridinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one and 8′-pyrimidinyl-dihydrospiro-[cycloalkyl]-pyrimido[1,2-a]pyrimidin-6-one derivatives'20077,247,638'8-Substituted-6,7,8,9-tetrahydropyrimido [1,2-a] pyrimidin-4-one derivatives.'20077,232,827'Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one derivatives'20077,223,750'Derivatives of 5-(pyridin-3-yl)-1-azabicyclo[3.2.1]octane, the preparation thereof and the application of same in therapeutics'20077,220,740'1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation and therapeutic use thereof'20077,217,715'Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives'20077,214,682'Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives'20077,211,581'Substituted 2-(diaza-bicyclo-alkyl)-pyrimidone derivatives'20077,119,087'4-(oxazolopyridin-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof'20067,067,521'1-[alkyl], 1-[(heteroaryl)alkyl] and 1-[(aryl)alkyl]-7pyridinyl-imidazo[1,2-alpha]pyrimidin-5(1H)-one derivatives'20067,022,697'4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]-nonane derivatives, preparation and therapeutic use thereof'20067,001,902'4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof'20066,998,399'4-(1,3,4-thiadiazol-2-yl)-1,4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof'20066,987,106'1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamide derivates, production and use thereof in therapeutics'20066,974,819'2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydoimidazo{1,2-a}pyrimidin-5(1H)one derivatives'20056,908,927'Pyridopyranoazepine derivatives, their preparation and their therapeutic application'20056,844,337'1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics'20056,835,730'4-heteroparyl-1,4-diazabicyclo3.2.2nonane, preparation and therapeutic use thereof'20046,635,645'2,5,-diazabicyclo2.2.1heptane derivatives, their preparation and therapeutic uses'20036,538,003'Pyridopyranoazepine derivatives, their preparation and their therapeutic application'20036,407,095'1,4-diazabicylo3,2,2nonane derivatives, their preparation and their therapeutic application'20026,255,319'5-aryl-3-(8-azabicyclo[3.2.1]oct-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives as 5-ht4 receptor ligands'20016,248,757'3-(Pyrrolidin-3-yl)-1,3,4-oxadiazol-2(3H)-one derivatives and their use as 5-HT4 ligands'20016,184,229'6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy'20016,143,761'2,3-dihydrofuro [3,2-.beta.]pyridin, preparation and application thereof in therapy'20006,057,321'1,4-diazabicyclo [2.2.2] oct-2-ylmethyl derivatives, their preparation and therapeutic application'20005,929,089'5-phenyl-3-(piperidin-4-yl)-1,3,4-oxadiazol-2(3H)-one derivatives for use as 5-Ht4 or H3 receptor ligands'19995,663,173'N-[(1,4-diazabicyclo[2.2.2] oct-2-yl)methyl] benzamide derivatives, their preparations and their application in therapeutics'19975,447,943'Novel benzopyran derivatives'19955,250,547'Benzopyran derivatives'19934,914,092'Benzothiazepin-4-one derivatives, their preparation and their application in therapy'1990Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1990–2015Based in Paris, FR· patent location history
1993–2014Based in Charenton-le-Pont, FR· patent location history
2005–2012Patents assigned to MITSUBISHI PHARMA CORP (20)· patent assignee history
2006–2013Patents assigned to SANOFI AVENTIS (33)· patent assignee history
2006Based in Pont du Chateau, FR· patent location history
2011–2015Patents assigned to LOCHEAD ALISTAIR (27)· patent assignee history
2012–2015Patents assigned to SAADY MOURAD (23)· patent assignee history
2012–2015Patents assigned to YAICHE PHILIPPE (21)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SANOFI AVENTIS | 33 | 2006–2013 |
| LOCHEAD ALISTAIRself | 27 | 2011–2015 |
| SAADY MOURAD | 23 | 2012–2015 |
| YAICHE PHILIPPE | 21 | 2012–2015 |
| MITSUBISHI PHARMA CORP | 20 | 2005–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Charenton-le-Pont, FR | 56 | 1993–2014 |
| Paris, FR | 18 | 1990–2015 |
| Pont du Chateau, FR | 1 | 2006 |